Yongli Shan
About Yongli Shan
Yongli Shan is a Senior Scientist specializing in Small Molecule Drug Discovery and Protein Homeostasis at Bristol Myers Squibb in Brisbane, California.
Current Role at Bristol Myers Squibb
Yongli Shan currently serves as a Senior Scientist in Small Molecule Drug Discovery, specializing in Protein Homeostasis at Bristol Myers Squibb. He is based in Brisbane, California, United States. In this role, he is involved in the research and development of small molecule drugs, focusing on maintaining protein homeostasis. His work likely involves advanced techniques and methodologies in molecular biology and drug discovery processes.
Previous Experience at MyoKardia
Prior to his position at Bristol Myers Squibb, Yongli Shan worked at MyoKardia as a Scientist I, Molecular Biology, for 10 months from 2020 to 2021. Also based in Brisbane, California, his role was focused on molecular biology research specifically related to molecular mechanisms of cardiomyopathies. His work at MyoKardia involved conducting experiments and contributing to the understanding of genetic factors impacting heart conditions.
Long-term Role at UT Southwestern Medical Center
Yongli Shan held the position of Instructor at UT Southwestern Medical Center in Dallas, Texas, United States, from 2009 to 2020. During his 11-year tenure, he focused on cellular and molecular biology research. His role included teaching responsibilities and conducting groundbreaking research in molecular cloning, protein engineering, and genetic engineering. His extensive research contributions during this time were instrumental in advancing scientific understanding in these areas.
Educational Background in Molecular Biology
Yongli Shan earned his Doctor of Philosophy (PhD) in Cell/Cellular and Molecular Biology from the University of Chinese Academy of Sciences, where he studied from 2002 to 2009. Prior to that, he obtained his Bachelor's degree in Biochemistry and Molecular Biology from Nankai University, completed between 1998 to 2002. His academic credentials have laid a strong foundation for his career in molecular biology and drug discovery.
Expertise in Genetic and Cellular Assay Development
With over 10 years of experience, Yongli Shan specializes in state-of-the-art molecular cloning, protein engineering, and genetic engineering of cell and animal lines. His expertise extends to next-generation sequencing (NGS), biomedical imaging, optical hardware design, and large-scale data analysis. His significant experience in co-ordinating multi-disciplinary system development and strong proficiency in genetic and cellular assay developments for disease and drug modalities underscore his capabilities in the field.